OnKure director granted 7,650 stock options
OnKure Therapeutics director Edward T. Mathers received a stock option grant representing 7,650 shares of Class A Common Stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
OnKure Therapeutics director Edward T. Mathers received a stock option grant representing 7,650 shares of Class A Common Stock. The option has an exercise price of $4.30 per share and expires on June 3, 2036. All 7,650 options will vest on the earlier of June 4, 2027 or the day before OnKure’s next annual meeting of stockholders, contingent on his continued service.
Insider Trade Summary
Grant/Award: 7,650 shares
Grant/Award
1 txn
Insider
Mathers Edward T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 7,650 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 7,650 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option will vest on the earlier of June 4, 2027 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.
Key Figures
Options granted: 7,650 options
Exercise price: $4.30 per share
Expiration date: June 3, 2036
+2 more
5 metrics
Options granted
7,650 options
Stock Option grant to Edward T. Mathers
Exercise price
$4.30 per share
Exercise price for the stock options
Expiration date
June 3, 2036
Option term end date
Underlying shares
7,650 shares
Class A Common Stock underlying the options
Vesting date trigger
June 4, 2027 or before next annual meeting
100% vesting condition, subject to continued service
Key Terms
Stock Option (right to buy), Class A Common Stock, exercise price, annual meeting of stockholders, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion_or_exercise_price: 4.3000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders financial
"the Issuer's next annual meeting of stockholders"
vesting financial
"100% of the shares subject to the option will vest"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did OnKure Therapeutics (OKUR) director Edward T. Mathers report on this Form 4?
Edward T. Mathers reported receiving a grant of stock options for 7,650 shares of OnKure Class A Common Stock. These options are compensation-related, not an open-market purchase or sale, and give him the right to buy shares at a fixed exercise price.
What are the key terms of Edward T. Mathers’ OnKure (OKUR) stock option grant?
The grant covers 7,650 stock options with an exercise price of $4.30 per share and an expiration date of June 3, 2036. Each option is tied to one share of OnKure’s Class A Common Stock as the underlying security.
When do Edward T. Mathers’ OnKure (OKUR) stock options vest?
One hundred percent of the 7,650 stock options will vest on the earlier of June 4, 2027, or the day prior to OnKure Therapeutics’ next annual meeting of stockholders, assuming Mathers continues as a service provider through that vesting date.
How many OnKure (OKUR) options does Edward T. Mathers hold after this grant?
After the transaction, Mathers holds 7,650 stock options directly, according to the Form 4. Each option is exercisable for one share of OnKure Class A Common Stock, subject to the vesting conditions and the June 3, 2036 expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
